T1	Participants 0 114	The cost-effectiveness of parasitologic diagnosis for malaria-suspected patients in an era of combination therapy.
T2	Participants 177 271	sub-Saharan Africa has prompted calls for increased use of parasitologic diagnosis for malaria
T3	Participants 312 341	rapid diagnostic tests (RDTs)
T4	Participants 373 538	guiding treatment of non-severe febrile illness at varying levels of malaria endemicity using data on test accuracy and costs collected as part of a Tanzanian trial.
T5	Participants 832 892	cost of $25 and $7 in the low and high transmission settings
T6	Participants 908 988	Cost-effectiveness would be worse if prescribers do not comply with test results
T7	Participants 990 1118	The cost of this additional benefit may be higher than many countries can afford without external assistance or lower RDT prices
